Total Debt Summary of ResMed Inc.

ResMed Inc.'s latest annual total debt in 2024 was 873.93 Million USD , down -44.68% from previous year.
ResMed Inc.'s latest quarterly total debt in 2024 FY was 873.93 Million USD , down -44.68% from previous quarter.
ResMed Inc. reported annual total debt of 1.57 Billion USD in 2023, up 72.19% from previous year.
ResMed Inc. reported annual total debt of 917.55 Million USD in 2022, up 15.6% from previous year.
ResMed Inc. reported quarterly total debt of 1.39 Billion USD for 2024 Q2, down -6.97% from previous quarter.
ResMed Inc. reported quarterly total debt of 873.93 Million USD for 2024 Q4, down -25.14% from previous quarter.

Annual Total Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Total Debt of ResMed Inc. (2024 - 1993)

Year	Total Debt	Total Debt Growth
2024	873.93 Million USD	-44.68%
2023	1.57 Billion USD	72.19%
2022	917.55 Million USD	15.6%
2021	793.71 Million USD	-38.91%
2020	1.29 Billion USD	2.24%
2019	1.27 Billion USD	351.53%
2018	281.45 Million USD	-73.91%
2017	1.07 Billion USD	-8.2%
2016	1.17 Billion USD	290.89%
2015	300.59 Million USD	-0.06%
2014	300.78 Million USD	0.0%
2013	300.78 Million USD	19.91%
2012	250.83 Million USD	150.43%
2011	100.16 Million USD	-17.69%
2010	121.68 Million USD	-24.76%
2009	161.73 Million USD	17.49%
2008	137.65 Million USD	18.67%
2007	115.99 Million USD	-4.2%
2006	121.08 Million USD	-30.56%
2005	174.36 Million USD	53.97%
2004	113.25 Million USD	0.0%
2003	113.25 Million USD	-8.11%
2002	123.25 Million USD	-17.83%
2001	150 Million USD	0.0%
2000	- USD	0.0%
1999	- USD	-100.0%
1998	200 Thousand USD	-66.67%
1997	600 Thousand USD	-33.33%
1996	900 Thousand USD	12.5%
1995	800 Thousand USD	100.0%
1994	400 Thousand USD	33.33%
1993	300 Thousand USD	0.0%

Year	Total Debt	Total Debt Growth
2024 FY	873.93 Million USD	-44.68%
2024 Q2	1.39 Billion USD	-6.97%
2024 Q4	873.93 Million USD	-25.14%
2024 Q1	1.49 Billion USD	-5.33%
2024 Q3	1.16 Billion USD	-16.09%
2023 FY	1.57 Billion USD	72.19%
2023 Q4	1.57 Billion USD	-8.36%
2023 Q2	1.93 Billion USD	108.4%
2023 Q3	1.72 Billion USD	-11.11%
2023 Q1	930.63 Million USD	1.43%
2022 FY	917.55 Million USD	15.6%
2022 Q1	950.1 Million USD	19.7%
2022 Q2	836.86 Million USD	-11.92%
2022 Q3	832.08 Million USD	-0.57%
2022 Q4	917.55 Million USD	10.27%
2021 Q3	868.8 Million USD	-10.04%
2021 Q2	965.8 Million USD	-18.77%
2021 Q1	1.18 Billion USD	-8.49%
2021 FY	793.71 Million USD	-38.91%
2021 Q4	793.71 Million USD	-8.64%
2020 Q1	1.3 Billion USD	2.73%
2020 FY	1.29 Billion USD	2.24%
2020 Q3	1.5 Billion USD	7.71%
2020 Q4	1.29 Billion USD	-13.78%
2020 Q2	1.39 Billion USD	7.15%
2019 Q4	1.27 Billion USD	-4.85%
2019 Q1	529.61 Million USD	88.17%
2019 FY	1.27 Billion USD	351.53%
2019 Q3	1.33 Billion USD	11.54%
2019 Q2	1.19 Billion USD	126.1%
2018 Q2	1.01 Billion USD	0.03%
2018 Q3	810 Million USD	-20.52%
2018 Q1	1.01 Billion USD	-5.54%
2018 Q4	281.45 Million USD	-65.25%
2018 FY	281.45 Million USD	-73.91%
2017 Q1	1.17 Billion USD	-0.16%
2017 Q3	1.16 Billion USD	-0.01%
2017 Q4	1.07 Billion USD	-7.68%
2017 FY	1.07 Billion USD	-8.2%
2017 Q2	1.16 Billion USD	-0.4%
2016 Q3	435.6 Million USD	8.47%
2016 Q1	500.58 Million USD	66.53%
2016 Q2	401.57 Million USD	-19.78%
2016 Q4	1.17 Billion USD	169.74%
2016 FY	1.17 Billion USD	290.89%
2015 Q1	375.7 Million USD	24.91%
2015 FY	300.59 Million USD	-0.06%
2015 Q3	460.58 Million USD	2.43%
2015 Q4	300.59 Million USD	-34.74%
2015 Q2	449.66 Million USD	19.69%
2014 Q3	395.8 Million USD	-9.18%
2014 Q2	435.81 Million USD	20.79%
2014 Q1	360.8 Million USD	19.96%
2014 Q4	300.78 Million USD	-24.01%
2014 FY	300.78 Million USD	0.0%
2013 Q3	340.81 Million USD	13.28%
2013 Q4	300.78 Million USD	-11.75%
2013 FY	300.78 Million USD	19.91%
2013 Q2	300.85 Million USD	13.17%
2013 Q1	265.83 Million USD	5.98%
2012 Q3	235.98 Million USD	4.21%
2012 Q2	226.45 Million USD	68.87%
2012 Q1	134.09 Million USD	33.88%
2012 Q4	250.83 Million USD	6.29%
2012 FY	250.83 Million USD	150.43%
2011 FY	100.16 Million USD	-17.69%
2011 Q4	100.16 Million USD	24.84%
2011 Q3	80.23 Million USD	24.67%
2011 Q2	64.35 Million USD	-31.39%
2011 Q1	93.8 Million USD	-22.92%
2010 Q1	163.38 Million USD	1.02%
2010 FY	121.68 Million USD	-24.76%
2010 Q2	145.12 Million USD	-11.18%
2010 Q4	121.68 Million USD	-15.32%
2010 Q3	143.69 Million USD	-0.98%
2009 Q3	159.58 Million USD	4.37%
2009 Q1	145.12 Million USD	5.43%
2009 Q2	152.9 Million USD	5.36%
2009 FY	161.73 Million USD	17.49%
2009 Q4	161.73 Million USD	1.35%
2008 Q2	132.62 Million USD	14.42%
2008 Q1	115.91 Million USD	-0.07%
2008 Q4	137.65 Million USD	4.12%
2008 Q3	132.2 Million USD	-0.32%
2008 FY	137.65 Million USD	18.67%
2007 Q1	120.3 Million USD	-0.64%
2007 Q3	114.57 Million USD	-14.21%
2007 FY	115.99 Million USD	-4.2%
2007 Q4	115.99 Million USD	1.25%
2007 Q2	133.54 Million USD	11.0%
2006 Q4	121.08 Million USD	25.51%
2006 FY	121.08 Million USD	-30.56%
2006 Q3	96.47 Million USD	-52.61%
2006 Q2	203.58 Million USD	10.34%
2006 Q1	184.5 Million USD	5.81%
2005 Q4	174.36 Million USD	53.97%
2005 Q1	113.25 Million USD	0.0%
2005 FY	174.36 Million USD	53.97%
2005 Q2	113.25 Million USD	0.0%
2005 Q3	113.25 Million USD	0.0%
2004 FY	113.25 Million USD	0.0%
2004 Q4	113.25 Million USD	0.0%
2004 Q3	113.25 Million USD	-2.23%
2004 Q2	115.82 Million USD	2.28%
2004 Q1	113.25 Million USD	0.0%
2003 FY	113.25 Million USD	-8.11%
2003 Q4	113.25 Million USD	0.0%
2003 Q3	113.25 Million USD	0.0%
2003 Q2	113.25 Million USD	-4.23%
2003 Q1	118.25 Million USD	-4.06%
2002 Q3	146 Million USD	-18.89%
2002 FY	123.25 Million USD	-17.83%
2002 Q1	180 Million USD	20.0%
2002 Q2	180 Million USD	0.0%
2002 Q4	123.25 Million USD	-15.58%
2001 Q3	75.42 Million USD	1576.16%
2001 FY	150 Million USD	0.0%
2001 Q2	4.5 Million USD	-35.71%
2001 Q1	7 Million USD	0.0%
2001 Q4	150 Million USD	98.87%
2000 Q2	- USD	0.0%
2000 Q4	- USD	0.0%
2000 Q1	- USD	0.0%
2000 Q3	- USD	0.0%
2000 FY	- USD	0.0%
1999 Q2	100 Thousand USD	-50.0%
1999 Q1	200 Thousand USD	0.0%
1999 Q4	- USD	-100.0%
1999 FY	- USD	-100.0%
1999 Q3	100 Thousand USD	0.0%
1998 Q4	200 Thousand USD	-33.33%
1998 FY	200 Thousand USD	-66.67%
1998 Q1	600 Thousand USD	0.0%
1998 Q2	400 Thousand USD	-33.33%
1998 Q3	300 Thousand USD	-25.0%
1997 Q1	900 Thousand USD	0.0%
1997 FY	600 Thousand USD	-33.33%
1997 Q3	700 Thousand USD	0.0%
1997 Q2	700 Thousand USD	-22.22%
1997 Q4	600 Thousand USD	-14.29%
1996 Q3	900 Thousand USD	0.0%
1996 Q4	900 Thousand USD	0.0%
1996 FY	900 Thousand USD	12.5%
1995 FY	800 Thousand USD	100.0%
1995 Q4	800 Thousand USD	0.0%
1994 Q4	400 Thousand USD	0.0%
1994 FY	400 Thousand USD	33.33%
1993 FY	300 Thousand USD	0.0%
1993 Q4	300 Thousand USD	0.0%

Peer Total Debt Comparison of ResMed Inc.

Name	Total Debt	Total Debt Difference
Alcon Inc.	5.14 Billion USD	83.008%
AptarGroup, Inc.	1.18 Billion USD	26.23%
Baxter International Inc.	14.36 Billion USD	93.916%
Becton, Dickinson and Company	15.87 Billion USD	94.496%
Bausch + Lomb Corporation	4.56 Billion USD	80.843%
Haemonetics Corporation	873.88 Million USD	-0.006%
Envista Holdings Corp	1.65 Billion USD	47.15%
Teleflex Incorporated	1.92 Billion USD	54.633%
Warby Parker Inc.	174.45 Million USD	-400.946%
West Pharmaceutical Services, Inc.	309 Million USD	-182.827%

Global Stocks Search

ResMed Inc. (RMD)

Total Debt Summary of ResMed Inc.

Annual Total Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Total Debt of ResMed Inc. (2024 - 1993)

Peer Total Debt Comparison of ResMed Inc.